Blog Posts

BIG PHARMA EARNINGS WATCH: ASTRAZENECA

Feb 14, 2020

Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Banked Read More

BIG PHARMA EARNINGS WATCH: ABBVIE

Feb 10, 2020

Big Pharma Giant Bests Wall Street Expectations After Hiking Prices In January Read More

BIG PHARMA EARNINGS WATCH: MERCK, GLAXOSMITHKLINE & BRISTOL-MYERS SQUIBB

Feb 7, 2020

Brand Name Drug Companies Keep the Good Times Rolling for Shareholders by Read More

BIG PHARMA WATCH: ANTI-COMPETITIVE CHARITY SCHEMES TAKE CENTER STAGE AT WAYS & MEANS HEARING

Feb 6, 2020

Testimony Highlights How Brand Name Drug Companies Use Nonprofits To Keep Read More

DOSE OF REALITY: BIG PHARMA’S INSULIN PRICE PREDICAMENT

Feb 4, 2020

Pharmaceutical Companies to Blame for Out-of-Control Prices for Life-Saving Read More

BIG PHARMA WATCH: BRAND NAME DRUG COMPANIES SHAMELESSLY SKIRT STATE TRANSPARENCY LAWS

Feb 3, 2020

Congressional Action Needed to Shine a Light on Big Pharma’s Egregious Read More

BIG PHARMA EARNINGS WATCH: AMGEN

Jan 31, 2020

Brand Name Drug Giant Beats Wall Street Expectations After Price Hikes on Read More

BIG PHARMA EARNINGS WATCH: ELI LILLY, ROCHE NOVARTIS & PFIZER

Jan 30, 2020

Brand Name Giants Keep Good Times Rolling Thanks to Series of Price Hikes on Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Jan 23, 2020

Prescription Drug Price Hikes Help Fuel Massive 32 Percent Boost to Profits Read More

WHAT THEY ARE SAYING: LOWERING Rx PRICES & HOLDING BIG PHARMA ACCOUNTABLE TOP PRIORITY IN 2020

Jan 14, 2020

Editorial Boards, Lawmakers and More Reiterate Need for Market-Based Solutions Read More

BIG PHARMA WATCH: HEADLINES FROM BIG PHARMA’S 2020 PRICE HIKE BONANZA

Jan 13, 2020

News from First Weeks of New Year Underscores Urgent Need for Action in Read More

BIG PHARMA WATCH: NEW STUDY FINDS PRICE HIKES DRIVEN BY QUEST FOR HIGHER PROFITS, NOT R&D

Dec 4, 2019

Analysis of Multiple Sclerosis Drug Pricing Undercuts Drug Makers’ Bogus Read More